Login to Your Account



Arno Therapeutic’s $30.7M Financing Lifts Onapristone into Clinic

By Marie Powers
Staff Writer

Wednesday, October 30, 2013
Arno Therapeutics Inc. hauled in $30.7 million through a private placement of common stock and warrants, more than doubling the amount raised by the company in last year’s $14.9 million private placement of convertible debentures.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription